AMERICAN INTERNATIONAL GROUP, INC. - TRANSPHORM INC ownership

TRANSPHORM INC's ticker is TGAN and the CUSIP is 89386L100. A total of 40 filers reported holding TRANSPHORM INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of TRANSPHORM INC
ValueSharesWeighting
Q3 2023$31,175
-29.5%
14,043
+7.9%
0.00%
Q2 2023$44,241
+1.0%
13,012
+18.5%
0.00%
Q1 2023$43,814
-25.2%
10,981
+2.0%
0.00%
Q4 2022$58,551
+8.4%
10,763
-0.4%
0.00%
Q3 2022$54,000
+42.1%
10,801
+7.6%
0.00%
Q2 2022$38,00010,0370.00%
Other shareholders
TRANSPHORM INC shareholders Q3 2023
NameSharesValueWeighting ↓
Worth Venture Partners, LLC 609,170$4,307,0001.99%
JACOB ASSET MANAGEMENT OF NEW YORK LLC 374,226$2,646,0001.61%
Kohlberg Kravis Roberts & Co. L.P. 22,175,980$156,784,0001.42%
Foundation Capital, LLC 136,004$962,0000.62%
Soros Fund Management 673,991$4,765,0000.07%
Polar Asset Management Partners Inc. 867,500$6,133,0000.07%
ExodusPoint Capital Management, LP 89,499$633,0000.01%
AMERIPRISE FINANCIAL INC 3,602,481$25,470,0000.01%
Weiss Asset Management LP 43,600$308,0000.01%
Ergoteles LLC 18,900$134,0000.01%
View complete list of TRANSPHORM INC shareholders